Related references
Note: Only part of the references are listed.The Role of 5-Aminolevulinic Acid in Enhancing Surgery for High-Grade Glioma, its Current Boundaries, and Future Perspectives: A Systematic Review
Alireza Mansouri et al.
CANCER (2016)
Current trends in the management of glioblastoma in a French University Hospital and associated direct costs
A. M. Henaine et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas
Darryl Lau et al.
JOURNAL OF NEUROSURGERY (2016)
The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review
Nicholas Ferraro et al.
NEUROSURGICAL REVIEW (2016)
The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection; a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI
M. Sam Eljamel et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2016)
Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study
Pilar Teixidor et al.
PLOS ONE (2016)
Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery
J. Slof et al.
NEUROLOGIA (2015)
A Pilot Cost-Effectiveness Analysis of Treatments in Newly Diagnosed High-Grade Gliomas: The Example of 5-Aminolevulinic Acid Compared With White-Light Surgery
Susana Esteves et al.
NEUROSURGERY (2015)
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
Costas G. Hadjipanayis et al.
NEUROSURGERY (2015)
Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery
Guillermo Aldave et al.
NEUROSURGERY (2013)
Intraoperative Fluorescence-Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid-Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies
Shiguang Zhao et al.
PLOS ONE (2013)
Risk factors for developing oral 5-aminolevulenic acid-induced side effects in patients undergoing fluorescence guided resection
Ivan Wong Hin Chung et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2013)
Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery
Walter Stummer et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Glioblastoma Multiforme Treatment with Clinical Trials for Surgical Resection (Aminolevulinic Acid)
David W. Roberts et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
An extent of resection threshold for newly diagnosed glioblastomas
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Carmustine implants for the treatment of newly diagnosed high-grade gliomas - A cost-utility analysis
Gabriel Rogers et al.
PHARMACOECONOMICS (2008)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
